Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / ADMS - Adamas Pharmaceuticals: Was It Overrated?


ADMS - Adamas Pharmaceuticals: Was It Overrated?

I have been following Adamas Pharmaceuticals (ADMS) ever since they were able to receive FDA approval for their flagship product GOCOVRI for PD dyskinesia and OFF. Since then, I have started writing for Seeking Alpha and decided to write about my Adamas journey. Most of my writing has been focused around quarterly earnings reports and how the market has reacted to those reports. This investment and my ADMS coverage have taught me a great deal about the interactions between the street, the company, the providers, the patients, and the investors. At one point,

Read more ...

Stock Information

Company Name: Adamas Pharmaceuticals Inc.
Stock Symbol: ADMS
Market: NASDAQ
Website: adamaspharma.com

Menu

ADMS ADMS Quote ADMS Short ADMS News ADMS Articles ADMS Message Board
Get ADMS Alerts

News, Short Squeeze, Breakout and More Instantly...